TLR2 and acute respiratory distress syndrome: Furthermore, the mRNA level of TLR2 was reduced after DHL treatment in the MRSA-ALI mouse model, suggesting that DHL might be a therapeutic candidate for Gram-positive bacteria-mediated inflammatory diseases.